Latest Articles in BioLogics
India Must Focus On Biopharmaceuticals To Feed The Growth Engine: Kiran Mazumdar Shaw
In an exclusive conversation with BW Healthcare World, Kiran Mazumdar Shaw, Executive Chairperson, Biocon & Biocon Biologics delineates on how Indian pharma can move up the value chain, while also speaking on Biocon's R&D investments and future plans
Read More
Biologics Manufacturing, An Opportunity To Partner With CRDMOs To Bring Speed, Mitigate Risks
Over the past few years, biopharmaceuticals, also known as biologics or biological medicinal products, have become a popular class of drugs. As per industry reports, the global biologics market is expected to be worth around USD 719.84 billion by 2030 and will expand at a compound annual growth rate
Read More